Residency · Residency · Chronic Pain Management

Percutaneous Disc Decompression

Introduction

Percutaneous disc decompression encompasses a group of minimally invasive techniques that reduce intradiscal pressure by removing or ablating a small volume of nucleus pulposus material. By decreasing the volume within a contained disc herniation, these procedures aim to reduce mechanical compression on adjacent neural structures and lower intradiscal pressure. The key technologies include nucleoplasty (coblation), the Dekompressor (mechanical aspiration), laser disc decompression, and intradiscal ozone injection.

Pathophysiologic Rationale

The fundamental principle behind percutaneous disc decompression rests on the hydraulics of a contained disc herniation. Intradiscal pressure within a contained herniation creates a hydraulic effect that maintains the annular bulge against the nerve root or thecal sac. Because the disc behaves as a closed hydraulic system when the annulus is intact, removing even a small volume of nuclear material (1-3 mL) can produce a disproportionate reduction in intradiscal pressure. Studies by Choy and Altman demonstrated that a 10-20% reduction in nuclear volume could yield a 50% or greater reduction in intradiscal pressure. This is the critical insight: the intact annulus fibrosus is essential, because these procedures rely on the closed hydraulic system to transmit volume reduction to the herniation site.

Indications and Patient Selection

The ideal candidate has a contained disc herniation (subligamentous, without extrusion or sequestration) confirmed by MRI, with radicular pain that correlates with the disc level and dermatomal distribution. Patients should have failed at least 6-8 weeks of conservative management including physical therapy, medications, and epidural steroid injections. The disc herniation should occupy less than one-third of the sagittal spinal canal diameter, and disc height should be preserved at greater than 50% of normal. Contraindications include extruded or sequestered disc herniations, severe spinal stenosis, significant spondylolisthesis, progressive neurological deficit (such as cauda equina syndrome), prior surgery at the same level, and infection.

Nucleoplasty (Coblation Technology)

Mechanism

Nucleoplasty uses a bipolar radiofrequency-driven plasma field — known as coblation — to ablate nuclear tissue at relatively low temperatures (40-70 degrees Celsius). The coblation wand creates a series of channels within the nucleus pulposus, each removing a small volume of tissue. Unlike conventional radiofrequency, coblation operates through a cold plasma field that dissociates molecular bonds without causing thermal necrosis of surrounding tissue.

Technique

The patient is positioned prone and a 17-gauge introducer needle is placed into the center of the nucleus pulposus via a posterolateral extrapedicular approach under fluoroscopic guidance. The Perc-DLE SpineWand is advanced through the introducer into the nucleus. The wand is set to ablation mode and slowly advanced to create a channel (6 seconds per channel), then switched to coagulation mode as it is withdrawn. Typically 6 channels are created in a radial pattern by rotating the wand between insertions. Total procedure time is approximately 15-20 minutes.

<image>Fluoroscopic and schematic illustration of the nucleoplasty procedure. The AP view shows the introducer needle positioned in the disc with the coblation wand extending into the nucleus pulposus. A cross-sectional axial diagram of the disc shows the six radial channels created by the coblation wand within the nucleus pulposus, arranged in a spoke-like pattern. The contained posterior disc herniation is shown with arrows indicating the reduction in intradiscal pressure and retraction of the annular bulge following volume reduction.</image>

Evidence

Singh et al. (2002) published an initial prospective study showing 79% of patients reporting significant pain relief at 12 months. Gerges et al. (2010) conducted a systematic review that found moderate evidence for short-term relief and limited evidence for long-term outcomes. Manchikanti et al. (2013) published an updated systematic review concluding that evidence was limited (Level III) for nucleoplasty in contained disc herniations. Comparative studies with epidural steroid injections or microdiscectomy are largely absent.

Dekompressor (Mechanical Aspiration)

Mechanism

The Dekompressor is a single-use, battery-powered device with a rotating helical tip that mechanically aspirates nucleus pulposus material. The auger-like probe rotates at a fixed speed and extracts nuclear tissue through a side port, collecting it in the cannula. It is designed to remove approximately 1 mL of nuclear material per treatment.

Technique

The approach is similar to nucleoplasty: a posterolateral fluoroscopically guided introducer needle is placed into the nucleus. The Dekompressor probe is advanced through the introducer into the central nucleus and activated for 2-3 minutes while gently advancing and withdrawing to maximize tissue extraction. The extracted tissue volume is confirmed visually in the cannula.

Evidence

Amoretti et al. (2006) published a prospective study of 50 patients showing 82% satisfactory outcomes at 12 months. Alo et al. (2010) reported a registry study demonstrating 72% improvement in VAS at 6 months. Overall evidence remains limited, with no sham-controlled RCTs published to date.

<image>Side-by-side comparison illustration of three percutaneous disc decompression devices: (1) Nucleoplasty coblation wand showing the plasma field at the tip creating tissue channels; (2) Dekompressor probe showing the rotating helical auger tip aspirating nuclear material through a side port; (3) Laser fiber (Nd:YAG) showing the laser tip vaporizing nuclear tissue with a small vapor cavity. Each device is shown positioned within a cross-section of the intervertebral disc with the nucleus pulposus and annulus fibrosus labeled.</image>

Other Percutaneous Disc Decompression Techniques

Percutaneous Laser Disc Decompression (PLDD)

PLDD uses an Nd:YAG or diode laser fiber inserted into the nucleus pulposus to vaporize disc tissue. Laser energy at 1000-1500 J creates a small vapor cavity within the nucleus, reducing intradiscal volume. Brouwer et al. (2015) conducted the Leiden-The Hague RCT comparing PLDD to conventional surgery and found that PLDD had significantly lower success rates at 1 year. Evidence quality is low to moderate, and PLDD has fallen out of favor in most practices.

Intradiscal Ozone Injection

This technique involves injection of an ozone-oxygen mixture (O3-O2) into the nucleus pulposus. Proposed mechanisms include oxidative breakdown of proteoglycans, reduction of disc volume, and anti-inflammatory effects. It is more commonly used in European and South American practices. Steppan et al. (2010) conducted a meta-analysis suggesting modest benefit but highlighted significant heterogeneity and low study quality.

Automated Percutaneous Lumbar Discectomy (APLD)

APLD was one of the earliest percutaneous decompression techniques and used a pneumatically driven probe to aspirate nuclear material. The Dekompressor is essentially its modern iteration. APLD has been largely replaced by newer technologies but remains historically important in the development of the field.

Outcomes and Comparative Evidence

No percutaneous disc decompression technique has demonstrated superiority over microdiscectomy in head-to-head trials. These procedures occupy a niche between conservative management and open surgery for carefully selected patients. Success rates across techniques average 60-80% for short-term relief in well-selected patients, but long-term data beyond 2 years is sparse for all percutaneous decompression methods. Insurance coverage varies significantly, and many payers consider these procedures investigational.

Clinical Pearls

The single most important selection criterion is a confirmed contained disc herniation — these procedures are ineffective and contraindicated for extruded or sequestered fragments. Always confirm that radicular symptoms correlate with the MRI findings and dermatomal distribution before proceeding. A negative straight-leg raise does not exclude the diagnosis, but discordance between imaging and clinical findings should prompt reconsideration. Percutaneous disc decompression is not a substitute for microdiscectomy in patients with progressive neurological deficits, cauda equina syndrome, or large extruded herniations. These techniques have the most favorable outcomes in patients with small contained herniations that have not responded to epidural steroid injections but do not warrant open surgery.

References

1. Singh V, Piryani C, Liao K, Nieschulz S. Percutaneous disc decompression using coblation (nucleoplasty) in the treatment of chronic discogenic pain. Pain Physician. 2002;5(3):250-259.
2. Manchikanti L, Falco FJ, Benyamin RM, et al. An update of the systematic assessment of mechanical lumbar disc decompression with nucleoplasty. Pain Physician. 2013;16(2 Suppl):SE25-54.
3. Brouwer PA, Brand R, van den Akker-van Marle ME, et al. Percutaneous laser disc decompression versus conventional microdiscectomy in sciatica: a randomized controlled trial. Spine J. 2015;15(5):857-865.
4. Amoretti N, David P, Grimaud A, et al. Clinical follow-up of 50 patients treated by percutaneous lumbar discectomy. Clin Imaging. 2006;30(1):1-8.

Read this lecture as Markdown